Conversations with Peter Boghossian Drug Treatments Medicine Feared & Trump Unlocked | Dr. Drew
9 snips
Apr 21, 2026 
Dr. Drew, physician and addiction medicine specialist known for public medical commentary, discusses treatments medicine avoids and controversial therapies. He covers ibogaine and psychedelics for addiction, ketamine and therapeutic mushrooms, peptides and hormone replacement, GLP-1 drugs and their risks, plus cancer advances, wearables, and what makes life worth living.
AI Snips
Chapters
Transcript
Episode notes
Hallucinogens May Help But Carry Lasting Risks
- Hallucinogenics show promise for addiction and mental health but risk long-term mood and personality changes.
- Dr. Drew notes ibogaine often leads to ~6 months' abstinence then relapse, with rare durable benefit and unclear patient selection criteria.
Question Peptide Hype Until Studies Arrive
- Be skeptical and require documentation before trusting peptide claims like BPC-157.
- Dr. Drew tried BPC-157 with NAC and glycine and saw subjective shoulder improvement but admits confounders and poor evidence base.
Treat Hormonal Deficits As Genuine Organ Failure
- Hormone replacement restores missing physiology and can be health-enhancing for women and men when indicated.
- Dr. Drew advocates HRT broadly but warns investigate causes of low testosterone in young men before prescribing.